Global Influenza Diagnostics Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Description

Influenza is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus poses a greater risk as compared to the influenza B virus. The B virus is responsible for 20% to 25% of infections globally. Proper collection, storage and transport of respiratory specimens are the essential first step for laboratory detection of influenza virus infections. Laboratory confirmation of influenza virus from throat, nasal and nasopharyngeal secretions or tracheal aspirate or washings is commonly performed using direct antigen detection, virus isolation, or detection of influenza-specific RNA by reverse transcriptase-polymerase chain reaction (RT-PCR).

According to our (Global Info Research) latest study, the global Influenza Diagnostics market size was valued at USD 2403.1 million in 2022 and is forecast to a readjusted size of USD 3620.3 million by 2029 with a CAGR of 6.0% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North America is the largest consumption place, with a consumption marker share nearly 53%. Following North America, Europe is the second largest consumption place with the consumption market share of 25%.

The main manufacturers are BD, Abbott (Include Alere), Roche, SIEMENS, Analytik Jena, Quidel, Thermo Fisher, Meridian Bioscience, BioMerieux, Sekisui Diagnostics, Response Biomedical, SA Scientific etc. BD is the largest manufacturer with about 19% market share.

This report is a detailed and comprehensive analysis for global Influenza Diagnostics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Influenza Diagnostics market size and forecasts, in consumption value ($ Million), 2018-2029
Global Influenza Diagnostics market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Influenza Diagnostics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Influenza Diagnostics market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Influenza Diagnostics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Influenza Diagnostics market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BD, Abbott (Include Alere), Roche, SIEMENS and Analytik Jena, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
Influenza Diagnostics market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    RIDT
    RT-PCR
    Cell Culture
    Others

Market segment by Application
    Hospitals
    POCT
    Others

Market segment by players, this report covers
    BD
    Abbott (Include Alere)
    Roche
    SIEMENS
    Analytik Jena
    Quidel
    Thermo Fisher
    Meridian Bioscience
    BioMerieux
    Sekisui Diagnostics
    Response Biomedical
    SA Scientific

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Influenza Diagnostics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Influenza Diagnostics, with revenue, gross margin and global market share of Influenza Diagnostics from 2018 to 2023.
Chapter 3, the Influenza Diagnostics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Influenza Diagnostics market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Influenza Diagnostics.
Chapter 13, to describe Influenza Diagnostics research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Influenza Diagnostics
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Influenza Diagnostics by Type
        1.3.1 Overview: Global Influenza Diagnostics Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Influenza Diagnostics Consumption Value Market Share by Type in 2022
        1.3.3 RIDT
        1.3.4 RT-PCR
        1.3.5 Cell Culture
        1.3.6 Others
    1.4 Global Influenza Diagnostics Market by Application
        1.4.1 Overview: Global Influenza Diagnostics Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Hospitals
        1.4.3 POCT
        1.4.4 Others
    1.5 Global Influenza Diagnostics Market Size & Forecast
    1.6 Global Influenza Diagnostics Market Size and Forecast by Region
        1.6.1 Global Influenza Diagnostics Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Influenza Diagnostics Market Size by Region, (2018-2029)
        1.6.3 North America Influenza Diagnostics Market Size and Prospect (2018-2029)
        1.6.4 Europe Influenza Diagnostics Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Influenza Diagnostics Market Size and Prospect (2018-2029)
        1.6.6 South America Influenza Diagnostics Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Influenza Diagnostics Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 BD
        2.1.1 BD Details
        2.1.2 BD Major Business
        2.1.3 BD Influenza Diagnostics Product and Solutions
        2.1.4 BD Influenza Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 BD Recent Developments and Future Plans
    2.2 Abbott (Include Alere)
        2.2.1 Abbott (Include Alere) Details
        2.2.2 Abbott (Include Alere) Major Business
        2.2.3 Abbott (Include Alere) Influenza Diagnostics Product and Solutions
        2.2.4 Abbott (Include Alere) Influenza Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Abbott (Include Alere) Recent Developments and Future Plans
    2.3 Roche
        2.3.1 Roche Details
        2.3.2 Roche Major Business
        2.3.3 Roche Influenza Diagnostics Product and Solutions
        2.3.4 Roche Influenza Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Roche Recent Developments and Future Plans
    2.4 SIEMENS
        2.4.1 SIEMENS Details
        2.4.2 SIEMENS Major Business
        2.4.3 SIEMENS Influenza Diagnostics Product and Solutions
        2.4.4 SIEMENS Influenza Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 SIEMENS Recent Developments and Future Plans
    2.5 Analytik Jena
        2.5.1 Analytik Jena Details
        2.5.2 Analytik Jena Major Business
        2.5.3 Analytik Jena Influenza Diagnostics Product and Solutions
        2.5.4 Analytik Jena Influenza Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Analytik Jena Recent Developments and Future Plans
    2.6 Quidel
        2.6.1 Quidel Details
        2.6.2 Quidel Major Business
        2.6.3 Quidel Influenza Diagnostics Product and Solutions
        2.6.4 Quidel Influenza Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Quidel Recent Developments and Future Plans
    2.7 Thermo Fisher
        2.7.1 Thermo Fisher Details
        2.7.2 Thermo Fisher Major Business
        2.7.3 Thermo Fisher Influenza Diagnostics Product and Solutions
        2.7.4 Thermo Fisher Influenza Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Thermo Fisher Recent Developments and Future Plans
    2.8 Meridian Bioscience
        2.8.1 Meridian Bioscience Details
        2.8.2 Meridian Bioscience Major Business
        2.8.3 Meridian Bioscience Influenza Diagnostics Product and Solutions
        2.8.4 Meridian Bioscience Influenza Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Meridian Bioscience Recent Developments and Future Plans
    2.9 BioMerieux
        2.9.1 BioMerieux Details
        2.9.2 BioMerieux Major Business
        2.9.3 BioMerieux Influenza Diagnostics Product and Solutions
        2.9.4 BioMerieux Influenza Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 BioMerieux Recent Developments and Future Plans
    2.10 Sekisui Diagnostics
        2.10.1 Sekisui Diagnostics Details
        2.10.2 Sekisui Diagnostics Major Business
        2.10.3 Sekisui Diagnostics Influenza Diagnostics Product and Solutions
        2.10.4 Sekisui Diagnostics Influenza Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Sekisui Diagnostics Recent Developments and Future Plans
    2.11 Response Biomedical
        2.11.1 Response Biomedical Details
        2.11.2 Response Biomedical Major Business
        2.11.3 Response Biomedical Influenza Diagnostics Product and Solutions
        2.11.4 Response Biomedical Influenza Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Response Biomedical Recent Developments and Future Plans
    2.12 SA Scientific
        2.12.1 SA Scientific Details
        2.12.2 SA Scientific Major Business
        2.12.3 SA Scientific Influenza Diagnostics Product and Solutions
        2.12.4 SA Scientific Influenza Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 SA Scientific Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Influenza Diagnostics Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Influenza Diagnostics by Company Revenue
        3.2.2 Top 3 Influenza Diagnostics Players Market Share in 2022
        3.2.3 Top 6 Influenza Diagnostics Players Market Share in 2022
    3.3 Influenza Diagnostics Market: Overall Company Footprint Analysis
        3.3.1 Influenza Diagnostics Market: Region Footprint
        3.3.2 Influenza Diagnostics Market: Company Product Type Footprint
        3.3.3 Influenza Diagnostics Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Influenza Diagnostics Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Influenza Diagnostics Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global Influenza Diagnostics Consumption Value Market Share by Application (2018-2023)
    5.2 Global Influenza Diagnostics Market Forecast by Application (2024-2029)

6 North America
    6.1 North America Influenza Diagnostics Consumption Value by Type (2018-2029)
    6.2 North America Influenza Diagnostics Consumption Value by Application (2018-2029)
    6.3 North America Influenza Diagnostics Market Size by Country
        6.3.1 North America Influenza Diagnostics Consumption Value by Country (2018-2029)
        6.3.2 United States Influenza Diagnostics Market Size and Forecast (2018-2029)
        6.3.3 Canada Influenza Diagnostics Market Size and Forecast (2018-2029)
        6.3.4 Mexico Influenza Diagnostics Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Influenza Diagnostics Consumption Value by Type (2018-2029)
    7.2 Europe Influenza Diagnostics Consumption Value by Application (2018-2029)
    7.3 Europe Influenza Diagnostics Market Size by Country
        7.3.1 Europe Influenza Diagnostics Consumption Value by Country (2018-2029)
        7.3.2 Germany Influenza Diagnostics Market Size and Forecast (2018-2029)
        7.3.3 France Influenza Diagnostics Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Influenza Diagnostics Market Size and Forecast (2018-2029)
        7.3.5 Russia Influenza Diagnostics Market Size and Forecast (2018-2029)
        7.3.6 Italy Influenza Diagnostics Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Influenza Diagnostics Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Influenza Diagnostics Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Influenza Diagnostics Market Size by Region
        8.3.1 Asia-Pacific Influenza Diagnostics Consumption Value by Region (2018-2029)
        8.3.2 China Influenza Diagnostics Market Size and Forecast (2018-2029)
        8.3.3 Japan Influenza Diagnostics Market Size and Forecast (2018-2029)
        8.3.4 South Korea Influenza Diagnostics Market Size and Forecast (2018-2029)
        8.3.5 India Influenza Diagnostics Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Influenza Diagnostics Market Size and Forecast (2018-2029)
        8.3.7 Australia Influenza Diagnostics Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Influenza Diagnostics Consumption Value by Type (2018-2029)
    9.2 South America Influenza Diagnostics Consumption Value by Application (2018-2029)
    9.3 South America Influenza Diagnostics Market Size by Country
        9.3.1 South America Influenza Diagnostics Consumption Value by Country (2018-2029)
        9.3.2 Brazil Influenza Diagnostics Market Size and Forecast (2018-2029)
        9.3.3 Argentina Influenza Diagnostics Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Influenza Diagnostics Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Influenza Diagnostics Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Influenza Diagnostics Market Size by Country
        10.3.1 Middle East & Africa Influenza Diagnostics Consumption Value by Country (2018-2029)
        10.3.2 Turkey Influenza Diagnostics Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Influenza Diagnostics Market Size and Forecast (2018-2029)
        10.3.4 UAE Influenza Diagnostics Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Influenza Diagnostics Market Drivers
    11.2 Influenza Diagnostics Market Restraints
    11.3 Influenza Diagnostics Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
    12.1 Influenza Diagnostics Industry Chain
    12.2 Influenza Diagnostics Upstream Analysis
    12.3 Influenza Diagnostics Midstream Analysis
    12.4 Influenza Diagnostics Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Influenza Diagnostics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Influenza Diagnostics Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Influenza Diagnostics Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Influenza Diagnostics Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. BD Company Information, Head Office, and Major Competitors
    Table 6. BD Major Business
    Table 7. BD Influenza Diagnostics Product and Solutions
    Table 8. BD Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. BD Recent Developments and Future Plans
    Table 10. Abbott (Include Alere) Company Information, Head Office, and Major Competitors
    Table 11. Abbott (Include Alere) Major Business
    Table 12. Abbott (Include Alere) Influenza Diagnostics Product and Solutions
    Table 13. Abbott (Include Alere) Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. Abbott (Include Alere) Recent Developments and Future Plans
    Table 15. Roche Company Information, Head Office, and Major Competitors
    Table 16. Roche Major Business
    Table 17. Roche Influenza Diagnostics Product and Solutions
    Table 18. Roche Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. Roche Recent Developments and Future Plans
    Table 20. SIEMENS Company Information, Head Office, and Major Competitors
    Table 21. SIEMENS Major Business
    Table 22. SIEMENS Influenza Diagnostics Product and Solutions
    Table 23. SIEMENS Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. SIEMENS Recent Developments and Future Plans
    Table 25. Analytik Jena Company Information, Head Office, and Major Competitors
    Table 26. Analytik Jena Major Business
    Table 27. Analytik Jena Influenza Diagnostics Product and Solutions
    Table 28. Analytik Jena Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. Analytik Jena Recent Developments and Future Plans
    Table 30. Quidel Company Information, Head Office, and Major Competitors
    Table 31. Quidel Major Business
    Table 32. Quidel Influenza Diagnostics Product and Solutions
    Table 33. Quidel Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. Quidel Recent Developments and Future Plans
    Table 35. Thermo Fisher Company Information, Head Office, and Major Competitors
    Table 36. Thermo Fisher Major Business
    Table 37. Thermo Fisher Influenza Diagnostics Product and Solutions
    Table 38. Thermo Fisher Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. Thermo Fisher Recent Developments and Future Plans
    Table 40. Meridian Bioscience Company Information, Head Office, and Major Competitors
    Table 41. Meridian Bioscience Major Business
    Table 42. Meridian Bioscience Influenza Diagnostics Product and Solutions
    Table 43. Meridian Bioscience Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. Meridian Bioscience Recent Developments and Future Plans
    Table 45. BioMerieux Company Information, Head Office, and Major Competitors
    Table 46. BioMerieux Major Business
    Table 47. BioMerieux Influenza Diagnostics Product and Solutions
    Table 48. BioMerieux Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 49. BioMerieux Recent Developments and Future Plans
    Table 50. Sekisui Diagnostics Company Information, Head Office, and Major Competitors
    Table 51. Sekisui Diagnostics Major Business
    Table 52. Sekisui Diagnostics Influenza Diagnostics Product and Solutions
    Table 53. Sekisui Diagnostics Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 54. Sekisui Diagnostics Recent Developments and Future Plans
    Table 55. Response Biomedical Company Information, Head Office, and Major Competitors
    Table 56. Response Biomedical Major Business
    Table 57. Response Biomedical Influenza Diagnostics Product and Solutions
    Table 58. Response Biomedical Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 59. Response Biomedical Recent Developments and Future Plans
    Table 60. SA Scientific Company Information, Head Office, and Major Competitors
    Table 61. SA Scientific Major Business
    Table 62. SA Scientific Influenza Diagnostics Product and Solutions
    Table 63. SA Scientific Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 64. SA Scientific Recent Developments and Future Plans
    Table 65. Global Influenza Diagnostics Revenue (USD Million) by Players (2018-2023)
    Table 66. Global Influenza Diagnostics Revenue Share by Players (2018-2023)
    Table 67. Breakdown of Influenza Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 68. Market Position of Players in Influenza Diagnostics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 69. Head Office of Key Influenza Diagnostics Players
    Table 70. Influenza Diagnostics Market: Company Product Type Footprint
    Table 71. Influenza Diagnostics Market: Company Product Application Footprint
    Table 72. Influenza Diagnostics New Market Entrants and Barriers to Market Entry
    Table 73. Influenza Diagnostics Mergers, Acquisition, Agreements, and Collaborations
    Table 74. Global Influenza Diagnostics Consumption Value (USD Million) by Type (2018-2023)
    Table 75. Global Influenza Diagnostics Consumption Value Share by Type (2018-2023)
    Table 76. Global Influenza Diagnostics Consumption Value Forecast by Type (2024-2029)
    Table 77. Global Influenza Diagnostics Consumption Value by Application (2018-2023)
    Table 78. Global Influenza Diagnostics Consumption Value Forecast by Application (2024-2029)
    Table 79. North America Influenza Diagnostics Consumption Value by Type (2018-2023) & (USD Million)
    Table 80. North America Influenza Diagnostics Consumption Value by Type (2024-2029) & (USD Million)
    Table 81. North America Influenza Diagnostics Consumption Value by Application (2018-2023) & (USD Million)
    Table 82. North America Influenza Diagnostics Consumption Value by Application (2024-2029) & (USD Million)
    Table 83. North America Influenza Diagnostics Consumption Value by Country (2018-2023) & (USD Million)
    Table 84. North America Influenza Diagnostics Consumption Value by Country (2024-2029) & (USD Million)
    Table 85. Europe Influenza Diagnostics Consumption Value by Type (2018-2023) & (USD Million)
    Table 86. Europe Influenza Diagnostics Consumption Value by Type (2024-2029) & (USD Million)
    Table 87. Europe Influenza Diagnostics Consumption Value by Application (2018-2023) & (USD Million)
    Table 88. Europe Influenza Diagnostics Consumption Value by Application (2024-2029) & (USD Million)
    Table 89. Europe Influenza Diagnostics Consumption Value by Country (2018-2023) & (USD Million)
    Table 90. Europe Influenza Diagnostics Consumption Value by Country (2024-2029) & (USD Million)
    Table 91. Asia-Pacific Influenza Diagnostics Consumption Value by Type (2018-2023) & (USD Million)
    Table 92. Asia-Pacific Influenza Diagnostics Consumption Value by Type (2024-2029) & (USD Million)
    Table 93. Asia-Pacific Influenza Diagnostics Consumption Value by Application (2018-2023) & (USD Million)
    Table 94. Asia-Pacific Influenza Diagnostics Consumption Value by Application (2024-2029) & (USD Million)
    Table 95. Asia-Pacific Influenza Diagnostics Consumption Value by Region (2018-2023) & (USD Million)
    Table 96. Asia-Pacific Influenza Diagnostics Consumption Value by Region (2024-2029) & (USD Million)
    Table 97. South America Influenza Diagnostics Consumption Value by Type (2018-2023) & (USD Million)
    Table 98. South America Influenza Diagnostics Consumption Value by Type (2024-2029) & (USD Million)
    Table 99. South America Influenza Diagnostics Consumption Value by Application (2018-2023) & (USD Million)
    Table 100. South America Influenza Diagnostics Consumption Value by Application (2024-2029) & (USD Million)
    Table 101. South America Influenza Diagnostics Consumption Value by Country (2018-2023) & (USD Million)
    Table 102. South America Influenza Diagnostics Consumption Value by Country (2024-2029) & (USD Million)
    Table 103. Middle East & Africa Influenza Diagnostics Consumption Value by Type (2018-2023) & (USD Million)
    Table 104. Middle East & Africa Influenza Diagnostics Consumption Value by Type (2024-2029) & (USD Million)
    Table 105. Middle East & Africa Influenza Diagnostics Consumption Value by Application (2018-2023) & (USD Million)
    Table 106. Middle East & Africa Influenza Diagnostics Consumption Value by Application (2024-2029) & (USD Million)
    Table 107. Middle East & Africa Influenza Diagnostics Consumption Value by Country (2018-2023) & (USD Million)
    Table 108. Middle East & Africa Influenza Diagnostics Consumption Value by Country (2024-2029) & (USD Million)
    Table 109. Influenza Diagnostics Raw Material
    Table 110. Key Suppliers of Influenza Diagnostics Raw Materials
List of Figures
    Figure 1. Influenza Diagnostics Picture
    Figure 2. Global Influenza Diagnostics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Influenza Diagnostics Consumption Value Market Share by Type in 2022
    Figure 4. RIDT
    Figure 5. RT-PCR
    Figure 6. Cell Culture
    Figure 7. Others
    Figure 8. Global Influenza Diagnostics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 9. Influenza Diagnostics Consumption Value Market Share by Application in 2022
    Figure 10. Hospitals Picture
    Figure 11. POCT Picture
    Figure 12. Others Picture
    Figure 13. Global Influenza Diagnostics Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 14. Global Influenza Diagnostics Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 15. Global Market Influenza Diagnostics Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 16. Global Influenza Diagnostics Consumption Value Market Share by Region (2018-2029)
    Figure 17. Global Influenza Diagnostics Consumption Value Market Share by Region in 2022
    Figure 18. North America Influenza Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Influenza Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 20. Asia-Pacific Influenza Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 21. South America Influenza Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 22. Middle East and Africa Influenza Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 23. Global Influenza Diagnostics Revenue Share by Players in 2022
    Figure 24. Influenza Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 25. Global Top 3 Players Influenza Diagnostics Market Share in 2022
    Figure 26. Global Top 6 Players Influenza Diagnostics Market Share in 2022
    Figure 27. Global Influenza Diagnostics Consumption Value Share by Type (2018-2023)
    Figure 28. Global Influenza Diagnostics Market Share Forecast by Type (2024-2029)
    Figure 29. Global Influenza Diagnostics Consumption Value Share by Application (2018-2023)
    Figure 30. Global Influenza Diagnostics Market Share Forecast by Application (2024-2029)
    Figure 31. North America Influenza Diagnostics Consumption Value Market Share by Type (2018-2029)
    Figure 32. North America Influenza Diagnostics Consumption Value Market Share by Application (2018-2029)
    Figure 33. North America Influenza Diagnostics Consumption Value Market Share by Country (2018-2029)
    Figure 34. United States Influenza Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 35. Canada Influenza Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 36. Mexico Influenza Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 37. Europe Influenza Diagnostics Consumption Value Market Share by Type (2018-2029)
    Figure 38. Europe Influenza Diagnostics Consumption Value Market Share by Application (2018-2029)
    Figure 39. Europe Influenza Diagnostics Consumption Value Market Share by Country (2018-2029)
    Figure 40. Germany Influenza Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 41. France Influenza Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 42. United Kingdom Influenza Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 43. Russia Influenza Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 44. Italy Influenza Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 45. Asia-Pacific Influenza Diagnostics Consumption Value Market Share by Type (2018-2029)
    Figure 46. Asia-Pacific Influenza Diagnostics Consumption Value Market Share by Application (2018-2029)
    Figure 47. Asia-Pacific Influenza Diagnostics Consumption Value Market Share by Region (2018-2029)
    Figure 48. China Influenza Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 49. Japan Influenza Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 50. South Korea Influenza Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 51. India Influenza Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 52. Southeast Asia Influenza Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 53. Australia Influenza Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 54. South America Influenza Diagnostics Consumption Value Market Share by Type (2018-2029)
    Figure 55. South America Influenza Diagnostics Consumption Value Market Share by Application (2018-2029)
    Figure 56. South America Influenza Diagnostics Consumption Value Market Share by Country (2018-2029)
    Figure 57. Brazil Influenza Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 58. Argentina Influenza Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 59. Middle East and Africa Influenza Diagnostics Consumption Value Market Share by Type (2018-2029)
    Figure 60. Middle East and Africa Influenza Diagnostics Consumption Value Market Share by Application (2018-2029)
    Figure 61. Middle East and Africa Influenza Diagnostics Consumption Value Market Share by Country (2018-2029)
    Figure 62. Turkey Influenza Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 63. Saudi Arabia Influenza Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 64. UAE Influenza Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 65. Influenza Diagnostics Market Drivers
    Figure 66. Influenza Diagnostics Market Restraints
    Figure 67. Influenza Diagnostics Market Trends
    Figure 68. Porters Five Forces Analysis
    Figure 69. Manufacturing Cost Structure Analysis of Influenza Diagnostics in 2022
    Figure 70. Manufacturing Process Analysis of Influenza Diagnostics
    Figure 71. Influenza Diagnostics Industrial Chain
    Figure 72. Methodology
    Figure 73. Research Process and Data Source